Perianal Fistulas in Crohn’s Patients Effectively Treated in Long Term with Cx601, Study Finds

Perianal Fistulas in Crohn’s Patients Effectively Treated in Long Term with Cx601, Study Finds
TiGenix’s lead compound Cx601 is a safe and effective long-term treatment of complex perianal fistulas in Crohn’s disease patients, a clinical trial reports. The positive results come from the 104-week extension period of ADMIRE-CD, a randomized, double-blind, placebo-controlled Phase 3 clinical trial (NCT01541579) looking to confirm the safety and efficacy of a single administration of Cx601 in

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Paul Tarantino says:

    Is this med an infusion,oral,or injectable? What are the unwanted side-effects of this drug? Thanks. And, can this be used for Fistula throughout the bowel.

Leave a Comment

Your email address will not be published. Required fields are marked *